Literature DB >> 1602196

Resolution of type 1 reaction in multibacillary Hansen's disease as a result of treatment with cyclosporine.

R I Frankel1, R T Mita, R Kim, F J Dann.   

Abstract

Type 1 Hansen's disease reaction (reversal reaction) is believed to result from a change in the immune response in patients with borderline Hansen's disease. The only effective therapy for significant type 1 reactions has been systemic corticosteroid therapy. Cyclosporine is an immunosuppressive drug which has been widely used in organ transplantation. We report a case of type 1 reaction complicating borderline lepromatous Hansen's disease. Cyclosporine therapy resulted in prompt and sustained resolution of the reaction. The possible mechanism of action of cyclosporine and the implications regarding the immunopathogenesis of type 1 reaction are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602196

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  4 in total

1.  Controlling leprosy.

Authors:  C Lienhardt; P E Fine
Journal:  BMJ       Date:  1992-07-25

Review 2.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.

Authors:  Saba M Lambert; Digafe T Alembo; Shimelis D Nigusse; Lawrence K Yamuah; Stephen L Walker; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2016-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.